Tina S. Ipe

Researcher

UAMS

Last publication 2026 Last refreshed 2026-05-16

faculty

15 h-index 57 pubs 733 cited

Research Areas

Links

ORCID Research Group

OverviewAI-generated summary

Tina S. Ipe's research focuses on transfusion medicine and its applications, particularly in the context of emerging infectious diseases and specific patient populations. She has investigated the use of therapeutic plasma exchange for conditions such as myasthenia gravis, as documented in a systematic literature review and meta-analysis. Her work has also explored the impact of COVID-19 on academic productivity among female physicians and researchers in transfusion medicine, as well as the broader effects of the pandemic on blood availability and transfusion practices in low- and middle-income countries.

Dr. Ipe has been involved in clinical trials evaluating the efficacy of COVID-19 convalescent plasma in hospitalized adults and the safety of pathogen-reduced red blood cells in complex cardiac surgery. Her research interests extend to the understanding and acceptance of cold-stored platelets. She has published 56 papers, with a total of 705 citations, and maintains an h-index of 15. Her collaborators include Horace J. Spencer, Anand N. Venkata, Ryan K Dare, and Juan Carlos Rico Crescencio, all from the University of Arkansas for Medical Sciences.

Metrics

h-index: 15
Publications: 57
Citations: 733

Selected Publications

A low dose is better than no dose: Is it time to consider lowering the US minimum plateletpheresis yield? (2026)

DOI OpenAlex
Current advances 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (<scp>AABB</scp>) Clinical Transfusion Medicine Committee (2025)

DOI OpenAlex
Transfusion Efficacy and Safety of Amustaline/Glutathione Pathogen-Reduced Red Blood Cells: Results of a Randomized, Controlled Phase III Trial (2024)

DOI OpenAlex
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis (2024)

DOI OpenAlex
Current advances in 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (<scp>AABB</scp>) Clinical Transfusion Medicine Committee (2024)

2 citations DOI OpenAlex
A review and analysis of outcomes in randomized clinical trials of plasma transfusion in patients with bleeding or for the prevention of bleeding: The <scp>BEST</scp> collaborative study (2024)

4 citations DOI OpenAlex
Gender differences in scholarly productivity of early‐career transfusion medicine physicians (2024)

2 citations DOI OpenAlex
Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study—protocol for a phase 3, randomized, controlled trial (2023)

13 citations DOI OpenAlex
Evaluation of the Efficacy &amp; Safety of Amustaline/Glutathione Pathogen Reduced RBCs in Complex Cardiac Surgery: the Red Cell Pathogen Inactivation (ReCePI) Study - Protocol for a Phase 3, Randomized, Controlled Trial (2023)

DOI OpenAlex
Transfusion medicine research in Africa: Insights from investigators in the field (2023)

2 citations DOI OpenAlex
Cold stored platelets – Increasing understanding and acceptance (2023)

10 citations DOI OpenAlex
Academic Productivity of Early Career Transfusion Medicine Specialists: A Workforce Study (2022)

4 citations DOI OpenAlex
Incidence of Red Cell Antibody Formation Following Massive Transfusion Protocol: Experience of a Single Institution (2022)

1 citation DOI OpenAlex
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19 (2022)

29 citations DOI OpenAlex
Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State (2022)

DOI OpenAlex